Skip to main content

Table 1 Clinical data of the patients included in the study

From: EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation

 

Tumors

Patients

 

tumor ID

prominence [mm]

LBD [mm]

SBD [mm]

cell type

ciliary body involvement

chr.3 status

chr.8 alteration

EFS methylation

patient ID

age at diagnosis [years]

sex

survival

metastatic death

follow up time [months]

set I

T1

5.9

11.9

11.7

sc

no

D3

AI

no

28914

69

m

alive

-

51

 

T2

5.8

11.2

10.6

sc

no

D3

AI

no

28101

69

f

alive

-

57

 

T3

14.0

19.0

n.d.

sc

no

D3

AI

no

25722

48

f

alive

-

67

 

T4

9.2

20.9

20.8

ec

no

D3

AI

partial

29311

39

m

deceased

yes

18

 

T5

11.4

19.0

11.9

sc

no

D3

no

full

29802

66

f

alive

-

47

 

T6

15.6

15.3

14.5

sc

no

D3

AI

no

22978

50

f

alive

-

81

 

T7

9.2

10.0

8.7

sc

no

D3

AI

no

29101

64

f

alive

-

52

 

T8

11.7

13.5

12.2

sc

no

D3

AI

partial

29380

72

m

alive

-

51

 

T9

10.8

n.d.

n.d.

sc

no

M3

AI

full

30545

65

m

alive

-

46

 

T10

12.0

13.4

11.9

sc

no

M3

no

partial

27745

67

f

deceased

no

45

 

T11

10.3

21.9

21.1

mc

yes

M3

AI

full

24905

66

m

deceased

yes

26

 

T12

9.8

17.0

13.5

mc

no

M3

AI

full

24903

64

f

deceased

yes

43

 

T13

10.6

21.3

17.4

mc

no

M3

AI

full

25726

57

m

deceased

yes

19

 

T14

9.8

25.0

21.0

sc

yes

M3

AI

full

24464

62

m

deceased

yes

22

 

T15

11.3

15.5

11.6

sc

yes

M3

AI

full

27587

61

f

deceased

yes

20

 

T16

8.5

n.d.

n.d.

sc

yes

M3

AI

full

25243

62

m

deceased

yes

18

set II

T17

7.1

11.2

10.6

sc

yes

D3

AI

no

14514

58

f

alive

-

125

 

T18

9.9

16.0

11.9

sc

yes

D3

AI

no

17003

55

m

alive

-

112

 

T19

10.4

15.5

14.4

sc

no

D3

AI

no

17453

19

f

alive

-

110

 

T20

9.8

16.1

14.5

sc

yes

D3

AI

no

18671

46

f

alive

-

104

 

T21

8.4

8.8

8.7

mc

no

D3

no

partial

19207

69

m

alive

-

102

 

T22

n.d.

9.4

8.6

sc

no

D3

no

no

21436

38

m

alive

-

89

 

T23

10.7

17.2

14.5

sc

no

D3

no

no

31091

63

m

alive

-

44

 

T24

16.2

21.3

17.2

sc

no

D3

AI

no

31412

45

m

alive

-

39

 

T25

6.0

13.4

12.1

sc

n.d.

D3

n.d.

no

33708

68

m

alive

-

29

 

T26

12.5

12.1

9.8

sc

no

D3

no

no

36500

73

f

alive

-

20

 

T27

12.0

22.7

18.9

sc

no

M3

AI

partial

17451

68

m

deceased

no

37

 

T28

10.5

24.3

19.6

mc

yes

M3

no

full

18465

77

m

deceased

yes

37

 

T29

12.3

16.0

15.2

mc

no

M3

AI

full

20012

76

m

deceased

yes

6

 

T30

10.7

17.7

16.6

mc

yes

M3

AI

full

21501

71

m

deceased

yes

46

 

T31

11.3

n.d.

n.d.

mc

yes

M3

AI

full

22095

74

m

deceased

yes

2

 

T32

11.9

16.9

15.4

sc

no

M3

AI

full

22543

69

m

deceased

yes

5

 

T33

9.3

20.0

n.d.

mc

no

M3

no

full

22805

70

m

deceased

no

18

 

T34

10.6

15.8

15.5

sc

yes

M3

AI

full

25720

61

m

deceased

yes

50

 

T35

13.7

n.d.

n.d.

sc

no

M3

AI

partial

26072

76

m

alive

-

61

 

T36

11.3

11.4

7.0

mc

yes

M3

AI

full

27766

63

m

deceased

yes

35

 

T37

10.1

12.9

10.7

sc

yes

M3

AI

full

29132

69

f

alive

-

52

 

T38

10.1

20.4

16.5

sc

nd

M3

no

full

29337

74

f

alive

-

51

 

T39

13.6

18.0

14.5

mc

no

M3

AI

full

32516

50

f

deceased

yes

30

 

T40

8.3

12.5

11.5

mc

no

M3

AI

full

34922

54

f

alive

-

24

  1. Methylation status of EFS as determined by direct sequencing of PCR products from bisulfite treated DNA; LBD, largest tumor diameter; SBD, smallest tumor diameter; M3, monosomy 3; D3, normal (retention of both alleles) chromosome 3 status; AI, allelic imbalance; m, male; f, female; sc, spindle cell; mc, mixed cell; ec, epitheloid cell type; n.d., not determined.